Diagnosis of copper toxicosis (CT) in Bedlington terriers by the quantitati
ve and qualitative assessment of copper (Cu) in, and pathology of, biopsies
has been largely superseded by a DNA-based assay which uses a microsatelli
te marker (CO4107) linked to the CT disease allele, A retrospective study w
as conducted comprising 154 liver biopsies from Bedlington terriers with 22
matched DNA markers to compare the two methods in the diagnosis of CT. For
the biopsy method, three categories (phenotypes) were identified based on
analytical and morphological criteria: 'unaffected' in 83 samples (54 per c
ent), where Cu was much less than 400 mug/g, and there was an absence of vi
sual Cu or liver damage; 'intermediate' in 18 samples (12 per cent), where
Cu was less than 400 mug/g, and there was limited histochemical Cu and no/e
quivocal damage; and 'affected' In 53 samples (34 per cent), where Cu was g
reater than 400 mug/g, there was histochemical Cu and liver damage was poor
ly related to Cu content, In the DNA assay, which was used alone on unrelat
ed individuals, the microsatellite marker failed to identify the CT status
of any of the groups, Liver biopsy remains a reliable Indicator of Cu accum
ulation and progressive liver disease In individual dogs, The microsatellit
e marker CO4107 has a predictive value only when supported by a pedigree.